Moderna (MRNA) stock trades flat as the U.S. cancels a $766M contract granted for the company to develop a vaccine against ...

The global Hydrogen Generation Market size is projected to be valued at USD 186.58 billion in 2024 and reach USD 317.39 ...

Cidara Therapeutics' CD388 is aimed at providing universal protection with a single yearly dose for each flu season. See why ...

Four expert-led educational events with Allergan Medical Institute (AMI), Science of Aging TM and Allergan Aesthetics (AA) Global Medical Affairs AMI symposia will focus on a new Allergan ...

Stifel has initiated Compass Pathways (NASDAQ:CMPS) with a buy rating saying that stakeholders are starting to agree there is a place for psychedelics as therapies for neuropsychiatric ailments. The ...

The Havak PH3 is built around a new three-lug action and quick-change barrel system and housed in a Seekins Mini Chassis. It’s also being made with open-source headspace and tenon specs, which would ...

It said: We take further confidence from the Ph3 patient populations being broadly similar to those included in the previous Ph2b trial. There was only one formal change to entry criteria in the ...

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers … ...

Cassava Sciences shares are plunging in premarket trading and are losing most of their value after the biotech firm said its experimental Simufilam drug aimed at treating Alzheimer’s disease ...

IgG4-related disease is a multiorgan, relapsing, fibroinflammatory, immune-mediated disorder with no approved therapy. Inebilizumab targets and depletes CD19+ B cells and may be effective for ...